Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy

Clinical trial NCT01070758 · COMPLETED

Trial details

NCT number: NCT01070758
Sponsor: Sheba Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Congenital Hyperinsulinism

Start date: 2010-02-01
Primary completion: 2015-02-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.